Skip to main content
OpenTrials
Completed

NCT Number: NCT03677063

Usefulness of Sterile Adhesive Dressing at the Exit-site of Peritoneal Dialysis Catheter

Infection of peritoneal dialysis fluid is a major complication in patients treated with peritoneal dialysis (PD). The aim of catheter emergence care is to reduce bacterial contamination of the peritoneum. The recommendations of the International Society of Peritoneal Dialysis do not provide information on the frequency of care delivery or the usefulness of a sterile adhesive dressing. Thus each treatment center applies a protocol of its own. Dressing is common practice although its safety and interest are not demonstrated.

The usefulness of dressing is still to be demonstrated. On the other hand, the efficacy of the application in prevention of a cream of mupirocin at emergence on the reduction of the risk of infection with staphylococcus aureus (SA), the most frequent germ found in peritonitis, has been demonstrated. A Spanish study showed that during a peritoneal infection at SA the site most frequently colonized by a similar strain of SA was the emergence of the catheter.

It can be considered that an infection of the dialysis liquid in PD is not only related to the quality of emergency care but also to manipulations during exchanges.

Given the number of patients involved in PD in France, it is difficult to obtain sufficient power to formally demonstrate the non-inferiority of the absence of dressing.

Therefore, the investigators propose a descriptive, exploratory study of events that may occur in PD when a dressing is not applied. This is a step prior to performing a multicenter randomized comparative study that will aim to show the non-inferiority of the absence of dressing compared to the application of a dressing on the incidence of fluid infection. peritoneal dialysis.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Caen University Hospital

Caen, 14033, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patient who has been informed and has given free and informed consent
  • patient affiliated to a social security scheme

Exclusion criteria

  • inclusion of the patient in another biomedical research protocol that influences the risk of infection
  • burial of the catheter before the initiation of dialysis treatment second attempt at treatment with peritoneal dialysis following catheter removal and resection
  • patient under curatorq
  • pregnant woman

Treatment and study plan

No dressing

Other

Then, care is the same and exit-site remains covered with an occlusive dressing to promote tunnel epithelialization and healing. The shower is forbidden during this period.

Primary outcomes

  1. Infectious event

    Time frame: 24 months

    Time until the occurrence of an infectious event:

    • Infection of Staphylococcus aureus peritoneal dialysis fluid (SA) within 24 months of follow-up
    • Infection of peritoneal dialysis fluid other than AS within 24 months of follow-up
    • Emergence infection during 24 months of follow-up
    • Peritonitis at SA and simultaneous presence of SA at emergence within 24 months of follow-up

Sponsors and collaborators

Lead sponsor

University Hospital, Caen

Other

Registry information

Official study title

Usefulness of Sterile Adhesive Dressing at the Exit-site of Peritoneal Dialysis Catheter: a Pilot Study

Acronym: PANCADIPE

Important dates

Study start
2019
Primary completion
2023
Study completion
2023
First posted
Sep 19, 2018
Registry last updated
Nov 28, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.